819
Participants
Start Date
August 31, 2001
Primary Completion Date
March 5, 2008
Study Completion Date
January 10, 2013
carboplatin
Arm 1 = 4 cycles vs Arm 2 = 8 cycles AUC5 (30 mins) day 1 of 21 day cycle
cisplatin
4 cycles 50mg/m2 (60 mins) day 1 of 21 day cycle
paclitaxel
Arm 1 = 4 cycles vs Arm 2 = 8 cycles 175mg/m2 (3 hours) day 1 of 21 day cycle
topotecan hydrochloride
"4 cycles~.75mg/m2 (30 mins) days 1-5 of 21 day cycle"
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
BCCA - Cancer Centre for the Southern Interior, Kelowna
Lions Gate Hospital, North Vancouver
BCCA - Fraser Valley Cancer Centre, Surrey
BCCA - Vancouver Cancer Centre, Vancouver
CancerCare Manitoba, Winnipeg
The Moncton Hospital, Moncton
Atlantic Health Sciences Corporation, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
QEII Health Sciences Center, Halifax
Northeast Cancer Center Health Sciences, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
Grand River Regional Cancer Centre, Kitchener
London Regional Cancer Program, London
Ottawa Health Research Institute - General Division, Ottawa
Niagara Health System, St. Catharines
Thunder Bay Regional Health Science Centre, Thunder Bay
Univ. Health Network-Princess Margaret Hospital, Toronto
Windsor Regional Cancer Centre, Windsor
PEI Cancer Treatment Centre,Queen Elizabeth Hospital, Charlottetown
CHUM - Hopital Notre-Dame, Montreal
Hopital du Sacre-Coeur de Montreal, Montreal
CHUQ-Pavillon Hotel-Dieu de Quebec, Québec
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
Grupo Español de Investigación en Cáncer de Ovario
OTHER
NCIC Clinical Trials Group
NETWORK